Goat Milk-Derived Formula vs. Undiluted Goat Milk in Infants Unable to Exclusively Breastfeed: Growth and Biomarker Analysis

NCT ID: NCT07225153

Last Updated: 2025-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-30

Study Completion Date

2026-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if Goat Milk-Derived Formula Alternatives (GMDFA) are safe and effective for infants who are unable to be exclusively breastfed. It will also study growth patterns, biological markers, and gut microbiome differences among infants receiving GMDFA, undiluted goat milk, or breast milk.

The main questions it aims to answer are:

1. Do infants receiving GMDFA show similar growth patterns to those who are breastfed?
2. Are biological markers of gut health and nutrition (such as calprotectin, lipocalin-2, CRP, and claudin) comparable between the groups?
3. How do feeding types (GMDFA, goat milk, or breast milk) influence the infant gut microbiome composition, metabolic pathways, and lipid profiles?
4. Is GMDFA a safe and nutritionally adequate feeding option for infants unable to be exclusively breastfed?

We will compare GMDFA, undiluted goat milk, and breast milk (reference group) to evaluate infant growth, gut health, and metabolic outcomes.

Participants will:

Be randomly assigned to one of three feeding groups: GMDFA, undiluted goat milk, or breastfed

Attend regular follow-up visits for growth measurements and sample collection (blood, stool, and breast milk where applicable)

Have feeding practices monitored and recorded through caregiver interviews and feeding logs

Additional Analyses:

Microbiome analysis: to identify gut bacterial diversity and composition across feeding groups Metagenomic analysis: to explore functional genes and metabolic pathways related to nutrition and gut health Lipidomic analysis: to assess differences in lipid and fatty acid profiles in breast milk, goat milk, and infant samples

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This community-based randomized controlled trial will evaluate the safety, nutritional adequacy, and biological effects of a Goat Milk-Derived Formula Alternative (GMDFA) among infants aged 8-10 weeks in Matiari, Pakistan, who are unable to exclusively breastfeed. The study includes three groups: (1) an intervention group receiving GMDFA prepared according to a standardized recipe developed for the study, (2) a control group receiving undiluted goat milk according to local feeding practices, and (3) an active comparator group of exclusively breastfed infants serving as a reference.

The intervention will last for 8 weeks. Primary and secondary outcomes will assess changes in lipidomic profiles, micronutrient status, gut inflammatory biomarkers (CRP, lipocalin-2, calprotectin, Claudin), and gut microbiome composition and diversity (Bifidobacterium, Firmicutes, Bacteroides, Clostridium, Lactobacillus). Anthropometric measurements including weight, length, and head circumference will be recorded at baseline and follow-up to evaluate infant growth outcomes.

The study aims to determine whether GMDFA provides a safe and nutritionally appropriate alternative to formula milk for infants who cannot be exclusively breastfed, with comparable biological and growth outcomes to breastfed infants. Findings from this study will inform the potential use of goat milk-based alternatives in low-resource settings where malnutrition and suboptimal breastfeeding rates are prevalent.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malnutrition (Calorie) Infant Nutrition Disorder Growth Flatering Gut Microbiome Lipidomics

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Infant nutrition goat milk Infant feeding practices Breastfeeding Breastfeeding Alternatives Alternate feeding practices Growth outcomes Infant growth metrics Gut microbiome Gut inflammation biomarkers Calprotectin Lipocalin-2 Claudin-2 C-reactive protein (CRP) Randomized controlled trial Rural Pakistan Infant health Malnutrition prevention Lipidomics Breast milk Metagenomics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a three-arm, parallel-group, community-based randomized controlled trial designed to compare the effects of Goat Milk-Derived Formula Alternative (GMDFA), undiluted goat milk, and exclusive breastfeeding on infant growth, gut microbiome, and metabolic health. Infants will be randomly assigned to one of the three groups and followed concurrently for a 8-week intervention period. Each group will receive its assigned feeding regimen in parallel, with no crossover between groups.
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

This is an open-label trial due to the visible differences between feeding interventions (GMDFA, undiluted goat milk, and breastfeeding). Participants, caregivers, and field investigators will be aware of group assignments.

However, to reduce potential bias, laboratory personnel conducting the microbiome, metagenomic, and lipidomic analyses will remain blinded to the feeding group assignments throughout sample processing and data analysis.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Goat Milk-Derived Formula Alternative (GMDFA)

Infants in this arm will receive Goat Milk-Derived Formula Alternative (GMDFA) as their primary source of feeding for 08 weeks. Growth, safety, and biological markers will be assessed through anthropometric measurements and laboratory analyses, including microbiome, metagenomic, and lipidomic profiling.

Group Type EXPERIMENTAL

GMDFA

Intervention Type DIETARY_SUPPLEMENT

GMDFA (GOat Milk-Derived Formula Alternative) is a goat milk-based formulation designed as an affordable alternative to commercial infant formula. It is prepared by diluting goat's milk to a standardized protein and micronutrient concentration according to study protocol. Infants in this arm will receive GMDFA from enrollment (08-10 weeks) until 16-18 weeks of age under close monitoring for growth and safety outcomes.

Undiluted Goat Milk (Current Practice)

Infants in this arm will receive undiluted goat milk according to local feeding practices, representing the current alternative to breastfeeding in the community. Growth and biological markers will be compared with the GMDFA and breastfed groups to evaluate safety and nutritional adequacy.

Group Type ACTIVE_COMPARATOR

Undiluted Goat Milk

Intervention Type OTHER

Infants will receive undiluted goat milk as per current local feeding practices for 8 weeks.

Breastfed Group (Reference Comparator)

Infants in this arm will be exclusively breastfed following WHO guidelines. No feeding intervention will be introduced. This group serves as the gold standard for comparison of growth metrics, microbiome composition, and metabolic biomarkers with the GMDFA and undiluted goat milk groups.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GMDFA

GMDFA (GOat Milk-Derived Formula Alternative) is a goat milk-based formulation designed as an affordable alternative to commercial infant formula. It is prepared by diluting goat's milk to a standardized protein and micronutrient concentration according to study protocol. Infants in this arm will receive GMDFA from enrollment (08-10 weeks) until 16-18 weeks of age under close monitoring for growth and safety outcomes.

Intervention Type DIETARY_SUPPLEMENT

Undiluted Goat Milk

Infants will receive undiluted goat milk as per current local feeding practices for 8 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Infants aged = 08 -10 weeks with WAZ better than -1.8. (NIPS \& ICF, 2019) Age Sex WAZ Weight in Kilograms 2 Month Boys WAZ\>-1.8 4-5 kg 2 Month Girls WAZ\>-1.8 4-5 kg Table 3: WAZ scores

* Living in Matiari District.
* Who has access to goat milk in their households.
* The Breastfeeding group: Women who exclusively breastfeeding and not giving and sort of formula or animal derived milk.
* Intervention Group: Women who do not breastfeed at all or give goat milk to their infants (2-3 feeds per day).
* No birth deformities

Exclusion Criteria

* • Infant birth weight \< WAZ -1.8 i.e. weight-for-age based on established growth standards, such as the World Health Organization (WHO).

* Birth deformities or disorders, such as genetic disorders, aerodigestive problems, or congenital anomalies.
* Plan to migrate during the next six months.
* We will exclude the women who exclusive breast feed and continue breast feeding for first 4 months.
* If the child is enrolled or included in any other interventional trial.
* Who does not have access to goat milk in their households.
* Are medically disqualified: Any potential participant who is deemed medically unfit for enrollment, due to the presence of severe or unstable health conditions that could compromise safety or interfere with the study outcomes, will be excluded from participation
Minimum Eligible Age

8 Weeks

Maximum Eligible Age

10 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fogarty International Center of the National Institute of Health

NIH

Sponsor Role collaborator

University of Colorado, Boulder

OTHER

Sponsor Role collaborator

Baker Heart Research Institute

OTHER

Sponsor Role collaborator

Aga Khan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Junaid Iqbal

Assistant Professor Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr. junaid Iqbal, PhD

Role: PRINCIPAL_INVESTIGATOR

Aga Khan University

Syed Asad Ali, MPH

Role: STUDY_DIRECTOR

Aga Khan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MATIARI Research & Training Centre

Matiāri, Sindh, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nimra Mazhar, M.Phil

Role: CONTACT

Phone: +923012354157

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dr. Fayyaz Umrani, MSPH

Role: primary

Dr. Sheraz Ahmed

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

George AD, Paul S, Wang T, Huynh K, Giles C, Mellett N, Duong T, Nguyen A, Geddes D, Mansell T, Saffery R, Vuillermin P, Ponsonby AL, Burgner D, Burugupalli S, Meikle PJ; Barwon Infant Study Investigator Team. Defining the lipid profiles of human milk, infant formula, and animal milk: implications for infant feeding. Front Nutr. 2023 Aug 30;10:1227340. doi: 10.3389/fnut.2023.1227340. eCollection 2023.

Reference Type BACKGROUND
PMID: 37712002 (View on PubMed)

Vandenplas Y, Zolnowska M, Berni Canani R, Ludman S, Tengelyi Z, Moreno-Alvarez A, Goh AEN, Gosoniu ML, Kirwan BA, Tadi M, Heine RG, Cinnamon Study Investigator Group. Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow's Milk Protein Allergy: A Randomized, Multi-Center Trial. Nutrients. 2022 Jan 26;14(3):530. doi: 10.3390/nu14030530.

Reference Type BACKGROUND
PMID: 35276889 (View on PubMed)

Akter S, Nishu NA. Malnutrition among under-5 children and its determinants in the southwestern coastal region of Bangladesh: A community-based study. BMJ Open. 2025 Jan 14;15(1):e090174. doi: 10.1136/bmjopen-2024-090174.

Reference Type BACKGROUND
PMID: 39809564 (View on PubMed)

Moreno-Avila IDM, Martinez-Linares JM, Garcia-Pintor S, Rubia-Ortega SM, Ortiz-Paneque J, El Messaoudi-Ouardani S, Cortes-Martin J. Perceptions on the Reasons Influencing the Choice and Abandonment of Exclusive Breastfeeding in Muslim and Christian Women: A Phenomenological Study. Nurs Health Sci. 2025 Sep;27(3):e70195. doi: 10.1111/nhs.70195.

Reference Type BACKGROUND
PMID: 40695358 (View on PubMed)

Reinhardt K, Fanzo J. Addressing Chronic Malnutrition through Multi-Sectoral, Sustainable Approaches: A Review of the Causes and Consequences. Front Nutr. 2014 Aug 15;1:13. doi: 10.3389/fnut.2014.00013. eCollection 2014.

Reference Type BACKGROUND
PMID: 25988116 (View on PubMed)

Omer S, Zakar R, Zakar MZ, Fischer F. The influence of social and cultural practices on maternal mortality: a qualitative study from South Punjab, Pakistan. Reprod Health. 2021 May 18;18(1):97. doi: 10.1186/s12978-021-01151-6.

Reference Type BACKGROUND
PMID: 34006307 (View on PubMed)

Pietrzak-Fiecko R, Kamelska-Sadowska AM. The Comparison of Nutritional Value of Human Milk with Other Mammals' Milk. Nutrients. 2020 May 14;12(5):1404. doi: 10.3390/nu12051404.

Reference Type BACKGROUND
PMID: 32422857 (View on PubMed)

Organization, W. H. (2005). Guiding principles for feeding non-breastfed children 6-24 months of age, World Health Organization.

Reference Type BACKGROUND

Organization, W. H. (2003). Complementary feeding: report of the global consultation, and summary of guiding principles for complementary feeding of the breastfed child, World Health Organization.

Reference Type BACKGROUND

Noh JW, Kim YM, Akram N, Yoo KB, Cheon J, Lee LJ, Kwon YD, Stekelenburg J. Factors Affecting Breastfeeding Practices in Sindh Province, Pakistan: A Secondary Analysis of Cross-Sectional Survey Data. Int J Environ Res Public Health. 2019 May 14;16(10):1689. doi: 10.3390/ijerph16101689.

Reference Type BACKGROUND
PMID: 31091768 (View on PubMed)

Nayik GA, Jagdale YD, Gaikwad SA, Devkatte AN, Dar AH, Dezmirean DS, Bobis O, Ranjha MMAN, Ansari MJ, Hemeg HA, Alotaibi SS. Recent Insights Into Processing Approaches and Potential Health Benefits of Goat Milk and Its Products: A Review. Front Nutr. 2021 Dec 6;8:789117. doi: 10.3389/fnut.2021.789117. eCollection 2021.

Reference Type BACKGROUND
PMID: 34938763 (View on PubMed)

Militao, E. M., Salvador, E. M., Silva, J. P., Uthman, O. A., Vinberg, S., & Macassa, G. (2022). Coping strategies for household food insecurity, and perceived health in an urban community in southern Mozambique: a qualitative study. Sustainability, 14(14), 8710.

Reference Type BACKGROUND

Kinsella HM, Hostnik LD, Toribio RE. Energy endocrine physiology, pathophysiology, and nutrition of the foal. J Am Vet Med Assoc. 2022 Oct 26;260(S3):S83-S93. doi: 10.2460/javma.22.08.0348.

Reference Type BACKGROUND
PMID: 36288202 (View on PubMed)

Kandhro F, Kazi TG, Afridi HI, Baig JA, Lashari AA, Lashari A. Determination of toxic elemental levels in whey milk of different cattle and human using an innovative digestion method: risk assessment for children < 6.0 months to 5 years. Environ Sci Pollut Res Int. 2023 Mar;30(14):41923-41936. doi: 10.1007/s11356-022-25059-1. Epub 2023 Jan 14.

Reference Type BACKGROUND
PMID: 36640239 (View on PubMed)

Kabir F, Iqbal J, Jamil Z, Iqbal NT, Mallawaarachchi I, Aziz F, Kalam A, Muneer S, Hotwani A, Ahmed S, Umrani F, Syed S, Sadiq K, Ma JZ, Moore SR, Ali A. Impact of enteropathogens on faltering growth in a resource-limited setting. Front Nutr. 2023 Jan 10;9:1081833. doi: 10.3389/fnut.2022.1081833. eCollection 2022.

Reference Type BACKGROUND
PMID: 36704796 (View on PubMed)

Iqbal NT, Syed S, Sadiq K, Khan MN, Iqbal J, Ma JZ, Umrani F, Ahmed S, Maier EA, Denson LA, Haberman Y, McNeal MM, Setchell KDR, Zhao X, Qureshi S, Shen L, Moskaluk CA, Liu TC, Yilmaz O, Brown DE, Barratt MJ, Kung VL, Gordon JI, Moore SR, Ali SA. Study of Environmental Enteropathy and Malnutrition (SEEM) in Pakistan: protocols for biopsy based biomarker discovery and validation. BMC Pediatr. 2019 Jul 22;19(1):247. doi: 10.1186/s12887-019-1564-x.

Reference Type BACKGROUND
PMID: 31331393 (View on PubMed)

Goraya MU, Li R, Mannan A, Gu L, Deng H, Wang G. Human circulating bacteria and dysbiosis in non-infectious diseases. Front Cell Infect Microbiol. 2022 Aug 24;12:932702. doi: 10.3389/fcimb.2022.932702. eCollection 2022.

Reference Type BACKGROUND
PMID: 36093202 (View on PubMed)

Ahmed F, Malik NI, Zia S, Akbar AS, Li X, Shahid M, Tang K. Rural mothers' beliefs and practices about diagnosis, treatment, and management of children health problems: A qualitative study in marginalized Southern Pakistan. Front Public Health. 2023 Jan 4;10:1001668. doi: 10.3389/fpubh.2022.1001668. eCollection 2022.

Reference Type BACKGROUND
PMID: 36684927 (View on PubMed)

Fantuz, F., et al. (2022). "Macro Minerals and Trace Elements in Milk of Dairy Buffaloes and Cows Reared in Mediterranean Areas." Beverages 8(3): 51.

Reference Type BACKGROUND

8. Fantuz, F., et al. (2016). Macro-and micronutrients in non-cow milk and products and their impact on human health. Non-bovine milk and milk products, Elsevier: 209-261.

Reference Type BACKGROUND

Corden E, Siddiqui SH, Sharma Y, Raghib MF, Adorno W 3rd, Zulqarnain F, Ehsan L, Shrivastava A, Ahmed S, Umrani F, Rahman N, Ali R, Iqbal NT, Moore SR, Ali SA, Syed S. Distance from Healthcare Facilities Is Associated with Increased Morbidity of Acute Infection in Pediatric Patients in Matiari, Pakistan. Int J Environ Res Public Health. 2021 Nov 7;18(21):11691. doi: 10.3390/ijerph182111691.

Reference Type BACKGROUND
PMID: 34770204 (View on PubMed)

6. Borton, R. E. (2018). The Influence Of Social And Economic Factors On Breastfeeding And Rural Mothers, Illinois State University.

Reference Type BACKGROUND

Bhutta ZA, Berkley JA, Bandsma RHJ, Kerac M, Trehan I, Briend A. Severe childhood malnutrition. Nat Rev Dis Primers. 2017 Sep 21;3:17067. doi: 10.1038/nrdp.2017.67.

Reference Type BACKGROUND
PMID: 28933421 (View on PubMed)

Bhutta ZA, Akseer N, Keats EC, Vaivada T, Baker S, Horton SE, Katz J, Menon P, Piwoz E, Shekar M, Victora C, Black R. How countries can reduce child stunting at scale: lessons from exemplar countries. Am J Clin Nutr. 2020 Sep 14;112(Suppl 2):894S-904S. doi: 10.1093/ajcn/nqaa153.

Reference Type BACKGROUND
PMID: 32692800 (View on PubMed)

Arif S, Khan H, Aslam M, Farooq M. Factors influencing exclusive breastfeeding duration in Pakistan: a population-based cross-sectional study. BMC Public Health. 2021 Nov 3;21(1):1998. doi: 10.1186/s12889-021-12075-y.

Reference Type BACKGROUND
PMID: 34732175 (View on PubMed)

Ali S, Ali SF, Imam AM, Ayub S, Billoo AG. Perception and practices of breastfeeding of infants 0-6 months in an urban and a semi-urban community in Pakistan: a cross-sectional study. J Pak Med Assoc. 2011 Jan;61(1):99-104.

Reference Type BACKGROUND
PMID: 22368919 (View on PubMed)

Alliance for Maternal and Newborn Health Improvement (AMANHI) mortality study group. Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study. Lancet Glob Health. 2018 Dec;6(12):e1297-e1308. doi: 10.1016/S2214-109X(18)30385-1. Epub 2018 Oct 22.

Reference Type BACKGROUND
PMID: 30361107 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

D43TW007585

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2025-11220-34303

Identifier Type: -

Identifier Source: org_study_id